101.7 FM
88.1HD2
8.85 c101.7 FM
88.1HD2
Health Canada approves remdesivir to treat severe COVID-19 symptoms
BY , Jul 28, 2020 8:35 PM - REPORT AN ERROR
Chief Public Health Officer of Canada Dr. Theresa Tam listens to a question at a news conference on the COVID-19 pandemic on Parliament Hill in Ottawa, on Tuesday, July 28, 2020. THE CANADIAN PRESS/Justin Tang
Health Canada has approved the use of remdesivir to treat patients with severe symptoms of COVID-19.
The federal agency says the antiviral drug may be used to treat patients who have pneumonia and require extra oxygen to help them breathe.
It's the first drug that Health Canada has authorized for the treatment of COVID-19.
Health Canada approved its use in adults and adolescents.
Remdesivir, which has been shown to shorten hospital stays, is administered intravenously and will be used only on patients that can be closely monitored.
Until now, a small number of patients have been treated with remdesivir in Canada under a special access program.
The drug has also been granted emergency or conditional authorization in the United States, Europe, Japan, Singapore and Australia.
Two clinical trials authorized by Health Canada are ongoing to evaluate the safety and effectiveness of remdesivir. Remdesivir is sold under the brand name Veklury and manufactured by Gilead Sciences Canada.
Share on
Related News
Sign up for the newsletter
We'll deliver best of entertainment right into your inboxWe love to hear from our listeners, so feel free to send us message
Message us on whatsapp
